Abstract
The sphingoplipid ceramide is responsible for a diverse range of biochemical and cellular responses including a putative role in modulating cell cycle progression. Herein, we describe that an accumulation of ceramide, achieved through the exogenous application of C6-ceramide or exposure to sphingomyelinase, induces a G2 arrest in Rhabdomyosarcoma (RMS) cell lines. Utilizing the RMS cell line RD, we show that this G2 arrest required the rapid induction of p21Cip1/Waf1 independent of DNA damage. This was followed at later time points (48 h) by the commitment to apoptosis. Apoptosis was prevented by Bcl-2 overexpression, but permitted the maintenance of elevated p21Cip1/Waf1 protein expression and the stabilization of the G2 arrest response. Inhibition of p21Cip1/Waf1 protein synthesis with cyclohexamide (CHX) or silencing of p21Cip1/Waf1 with siRNA, prevented ceramide-mediated G2 arrest and the late induction of apoptosis. Further, adopting the recent discovery that murine double minute 2 (MDM2) controls p21Cip1/Waf1 expression by presenting this CDK inhibitor to the proteasome for degradation, RD cells overexpressing MDM2 abrogated ceramide-mediated p21Cip1/Waf1 induction, G2 arrest and the late ensuing apoptosis. Collectively, these data further support the notion that ceramide accumulation can modulate cell cycle progression. Additionally, these observations highlight MDM2 expression and proteasomal activity as key determinants of the cellular response to ceramide accumulation.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Accession codes
Abbreviations
- ASMase:
-
acid sphingomyelinase
- ARMS:
-
alveolar Rhabdomyosarcoma
- ANOVA:
-
analysis of variance
- BrdU:
-
5-bromo-2′-deoxy-uridine
- CDK:
-
cyclin-dependent kinase
- CDKI:
-
cyclin-dependent kinase inhibitor
- CHX:
-
cyclohexamide
- DAGK:
-
diacylglycerol kinase
- DSB:
-
double-strand breaks
- ERMS:
-
embryonal Rhabdomyosarcoma
- FB1:
-
fumonisin B1
- IR:
-
ionizing radiation
- MDM2:
-
murine double minute 2
- NSMase:
-
neutral sphngomyelinase
- PBS:
-
phosphate-buffered saline
- Rb:
-
retinoblastoma
- RT-PCR:
-
reverse transcription-polymerase chain reaction
- RMS:
-
Rhabdomyosarcoma
- SMase:
-
sphingomyelinase
References
Ogretmen B, Hannun YA . Biologically active sphingolipids in cancer pathogenesis and treatment. Nat Rev Cancer 2004; 4: 604–616.
Goni FM, Alonso A . Biophysics of sphingolipids I. Membrane properties of sphingosine. Ceramides and other simple sphingolipids. Biochim Biophys Acta 2006; 1758: 1902–1921.
Phillips DC, Griffiths HR . Ceramide induces a loss in cytosolic peroxide levels in mononuclear cells. Biochem J 2003; 375: 567–579.
Lee JY, Bielawska AE, Obeid LM . Regulation of cyclin-dependent kinase 2 activity by ceramide. Exp Cell Res 2000; 261: 303–311.
Altura BM, Gebrewold A, Zheng T, Altura BT . Sphingomyelinase and ceramide analogs induce vasoconstriction and leukocyte-endothelial interactions in cerebral venules in the intact rat brain: insight into mechanisms and possible relation to brain injury and stroke. Brain Res Bull 2002; 58: 271–278.
Martin S, Phillips DC, Szekely-Szucs K, Elghazi L, Desmots F, Houghton JA . Cyclooxygenase-2 inhibition sensitizes human colon carcinoma cells to TRAIL-induced apoptosis through clustering of DR5 and concentrating death-inducing signaling complex components into ceramide-enriched caveolae. Cancer Res 2005; 65: 11447–11458.
Daido S, Kanzawa T, Yamamoto A, Takeuchi H, Kondo Y, Kondo S . Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells. Cancer Res 2004; 64: 4286–4293.
Phillips DC, Allen K, Griffiths HR . Synthetic ceramides induce growth arrest or apoptosis by altering cellular redox status. Arch Biochem Biophys 2002; 407: 15–24.
Lee JY, Leonhardt LG, Obeid LM . Cell-cycle-dependent changes in ceramide levels preceding retinoblastoma protein dephosphorylation in G2/M. Biochem J 1998; 334(Part 2): 457–461.
Sherr CJ, Roberts JM . Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 1995; 9: 1149–1163.
Bunz F, Dutriaux A, Lengauer C, Waldman T, Zhou S, Brown JP et al. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 1998; 282: 1497–1501.
Jin Y, Lee H, Zeng SX, Dai MS, Lu H . MDM2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation. EMBO J 2003; 22: 6365–6377.
Liu CW, Corboy MJ, DeMartino GN, Thomas PJ . Endoproteolytic activity of the proteasome. Science 2003; 299: 408–411.
Sheaff RJ, Singer JD, Swanger J, Smitherman M, Roberts JM, Clurman BE . Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination. Mol Cell 2000; 5: 403–410.
Zhang Z, Wang H, Li M, Agrawal S, Chen X, Zhang R . MDM2 is a negative regulator of p21WAF1/CIP1, independent of p53. J Biol Chem 2004; 279: 16000–16006.
Corvi R, Savelyeva L, Breit S, Wenzel A, Handgretinger R, Barak J et al. Non-syntenic amplification of MDM2 and MYCN in human neuroblastoma. Oncogene 1995; 10: 1081–1086.
Leach FS, Tokino T, Meltzer P, Burrell M, Oliner JD, Smith S et al. p53 Mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res 1993; 53: 2231–2234.
Oliner JD, Kinzler KW, Meltzer PS, George DL, Vogelstein B . Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 1992; 358: 80–83.
Reifenberger G, Liu L, Ichimura K, Schmidt EE, Collins VP . Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res 1993; 53: 2736–2739.
Bartel F, Taylor AC, Taubert H, Harris LC . Novel mdm2 splice variants identified in pediatric rhabdomyosarcoma tumors and cell lines. Oncol Res 2000; 12: 451–457.
Taylor AC, Shu L, Danks MK, Poquette CA, Shetty S, Thayer MJ et al. P53 mutation and MDM2 amplification frequency in pediatric rhabdomyosarcoma tumors and cell lines. Med Pediatr Oncol 2000; 35: 96–103.
Zhang R, Wang H . MDM2 oncogene as a novel target for human cancer therapy. Curr Pharm Des 2000; 6: 393–416.
Haupt Y, Maya R, Kazaz A, Oren M . Mdm2 promotes the rapid degradation of p53. Nature 1997; 387: 296–299.
Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L et al. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2′s inhibition of p53. Cell 1998; 92: 713–723.
Martin K, Trouche D, Hagemeier C, Sorensen TS, La Thangue NB, Kouzarides T . Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature 1995; 375: 691–694.
Balint E, Bates S, Vousden KH . Mdm2 binds p73 alpha without targeting degradation. Oncogene 1999; 18: 3923–3929.
Breitfeld PP, Meyer WH . Rhabdomyosarcoma: new windows of opportunity. Oncologist 2005; 10: 518–527.
Gartel AL, Tyner AL . The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol Cancer Ther 2002; 1: 639–649.
Garcia-Ruiz C, Mari M, Morales A, Colell A, Ardite E, Fernandez-Checa JC . Human placenta sphingomyelinase, an exogenous acidic pH-optimum sphingomyelinase, induces oxidative stress, glutathione depletion, and apoptosis in rat hepatocytes. Hepatology 2000; 32: 56–65.
Reed JC . Bcl-2 family proteins: regulators of apoptosis and chemoresistance in hematologic malignancies. Semin Hematol 1997; 34: 9–19.
Kang KH, Kim WH, Choi KH . p21 promotes ceramide-induced apoptosis and antagonizes the antideath effect of Bcl-2 in human hepatocarcinoma cells. Exp Cell Res 1999; 253: 403–412.
Oh WJ, Kim WH, Kang KH, Kim TY, Kim MY, Choi KH . Induction of p21 during ceramide-mediated apoptosis in human hepatocarcinoma cells. Cancer Lett 1998; 129: 215–222.
Alesse E, Zazzeroni F, Angelucci A, Giannini G, Di Marcotullio L, Gulino A . The growth arrest and downregulation of c-myc transcription induced by ceramide are related events dependent on p21 induction, Rb underphosphorylation and E2F sequestering. Cell Death Differ 1998; 5: 381–389.
Taylor WR, Stark GR . Regulation of the G2/M transition by p53. Oncogene 2001; 20: 1803–1815.
Dash BC, El-Deiry WS . Phosphorylation of p21 in G2/M promotes cyclin B-Cdc2 kinase activity. Mol Cell Biol 2005; 25: 3364–3387.
Dbaibo GS, Pushkareva MY, Jayadev S, Schwarz JK, Horowitz JM, Obeid LM et al. Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. Proc Natl Acad Sci USA 1995; 92: 1347–1351.
Spyridopoulos I, Mayer P, Shook KS, Axel DI, Viebahn R, Karsch KR . Loss of cyclin A and G1-cell cycle arrest are a prerequisite of ceramide-induced toxicity in human arterial endothelial cells. Cardiovasc Res 2001; 50: 97–107.
Zhu XF, Liu ZC, Xie BF, Feng GK, Zeng YX . Ceramide induces cell cycle arrest and upregulates p27kip in nasopharyngeal carcinoma cells. Cancer Lett 2003; 193: 149–154.
Rani CS, Abe A, Chang Y, Rosenzweig N, Saltiel AR, Radin NS et al. Cell cycle arrest induced by an inhibitor of glucosylceramide synthase. Correlation with cyclin-dependent kinases. J Biol Chem 1995; 270: 2859–2867.
Zhou BB, Chaturvedi P, Spring K, Scott SP, Johanson RA, Mishra R et al. Caffeine abolishes the mammalian G(2)/M DNA damage checkpoint by inhibiting ataxia-telangiectasia-mutated kinase activity. J Biol Chem 2000; 275: 10342–10348.
Skapek SX, Rhee J, Spicer DB, Lassar AB . Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 1995; 267: 1022–1024.
Gartel AL, Radhakrishnan SK . Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res 2005; 65: 3980–3985.
Hazelton BJ, Houghton JA, Parham DM, Douglass EC, Torrance PM, Holt H et al. Characterization of cell lines derived from xenografts of childhood rhabdomyosarcoma. Cancer Res 1987; 47: 4501–4507.
Phillips DC, Martin S, Doyle BT, Houghton JA . Sphingosine-induced apoptosis in rhabdomyosarcoma cell lines is dependent on pre-mitochondrial Bax activation and post-mitochondrial caspases. Cancer Res 2007; 67: 756–764.
Author information
Authors and Affiliations
Corresponding author
Additional information
Edited by H Ichijo
Supplementary Information accompanies the paper on Cell Death and Differentiation website (http://www.nature.com/cdd)
Rights and permissions
About this article
Cite this article
Phillips, D., Hunt, J., Moneypenny, C. et al. Ceramide-induced G2 arrest in rhabdomyosarcoma (RMS) cells requires p21Cip1/Waf1 induction and is prevented by MDM2 overexpression. Cell Death Differ 14, 1780–1791 (2007). https://doi.org/10.1038/sj.cdd.4402198
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.cdd.4402198
Keywords
This article is cited by
-
Tumor suppressive functions of ceramide: evidence and mechanisms
Apoptosis (2015)
-
Proof-of-concept rare cancers in drug development: the case for rhabdomyosarcoma
Oncogene (2014)
-
Loss of MEF2D expression inhibits differentiation and contributes to oncogenesis in rhabdomyosarcoma cells
Molecular Cancer (2013)
-
Ceramide-orchestrated signalling in cancer cells
Nature Reviews Cancer (2013)
-
The roles of bioactive sphingolipids in resveratrol-induced apoptosis in HL60 acute myeloid leukemia cells
Journal of Cancer Research and Clinical Oncology (2011)
